The Effect of Therapeutic Doses of Culinary Spices in Metabolic Syndrome: A Randomized Controlled Trial
- PMID: 38892617
- PMCID: PMC11175078
- DOI: 10.3390/nu16111685
The Effect of Therapeutic Doses of Culinary Spices in Metabolic Syndrome: A Randomized Controlled Trial
Erratum in
-
Correction: Al Dhaheri et al. The Effect of Therapeutic Doses of Culinary Spices in Metabolic Syndrome: A Randomized Controlled Trial. Nutrients 2024, 16, 1685.Nutrients. 2024 Nov 5;16(22):3791. doi: 10.3390/nu16223791. Nutrients. 2024. PMID: 39599760 Free PMC article.
Abstract
Non-communicable diseases (NCDs) place a significant burden on global health and the healthcare systems which support it. Metabolic syndrome is a major risk factor for a large number of NCDs; however, treatments remain limited. Previous research has shown the protective benefits of edible dietary spices on key components of metabolic syndrome. Therefore we performed a 12-week double-blind, placebo-controlled, randomized, clinical trial to evaluate the effect of ginger (Zingiber officinale), cinnamon (Cinnamomum), and black seed (Nigella sativa) consumption on blood glucose, lipid profiles, and body composition in 120 participants with, or at risk of, metabolic syndrome. Each participant consumed 3 g/day of powder (spice or placebo). Data related to different parameters were collected from participants at the baseline, midpoint, and endpoint of the intervention. Over the 12-week interventions, there was an improvement in a number of biochemical indices of metabolic syndrome, including fasting blood glucose, HbA1c, LCL, and total cholesterol associated with supplementation with the spices when compared to a placebo. This study provides evidence to support the adjunct use of supplementation for those at risk of metabolic syndrome and its sequelae.
Keywords: black seed; cinnamon; dyslipidemia; edible spices; ginger; hyperglycemia; hypertension; metabolic syndrome.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- Forouzanfar M.H., Afshin A., Alexander L.T., Anderson H.R., Bhutta Z.A., Biryukov S., Brauer M., Burnett R., Cercy K., Charlson F.J. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: A systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388:1659. doi: 10.1016/S0140-6736(16)31679-8. - DOI - PMC - PubMed
-
- Tonkin A. The metabolic syndrome–a growing problem. Eur. Heart J. Suppl. 2004;6:A37–A42. doi: 10.1016/j.ehjsup.2004.01.009. - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
